NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 221 filers reported holding NATERA INC in Q2 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,057 | -92.0% | 1,538 | -91.2% | 0.00% | -92.9% |
| Q2 2023 | $851,988 | +819119.2% | 17,509 | +836.3% | 0.03% | +833.3% |
| Q1 2023 | $104 | -75.2% | 1,870 | -82.1% | 0.00% | -82.4% |
| Q4 2022 | $419 | -99.1% | 10,433 | +911.9% | 0.02% | +1600.0% |
| Q3 2022 | $45,000 | -89.8% | 1,031 | -91.7% | 0.00% | -90.0% |
| Q2 2022 | $442,000 | -30.3% | 12,468 | -20.0% | 0.01% | +66.7% |
| Q1 2022 | $634,000 | -23.8% | 15,584 | +75.0% | 0.01% | -57.1% |
| Q4 2021 | $832,000 | +264.9% | 8,904 | +336.3% | 0.01% | +133.3% |
| Q3 2021 | $228,000 | -37.5% | 2,041 | -36.5% | 0.01% | -33.3% |
| Q2 2021 | $365,000 | -52.3% | 3,216 | -57.4% | 0.01% | -30.8% |
| Q1 2021 | $766,000 | +220.5% | 7,545 | +214.8% | 0.01% | +85.7% |
| Q4 2020 | $239,000 | +143.9% | 2,397 | +76.4% | 0.01% | +600.0% |
| Q3 2020 | $98,000 | -60.6% | 1,359 | -72.8% | 0.00% | -90.0% |
| Q2 2020 | $249,000 | +522.5% | 4,997 | +317.8% | 0.01% | +233.3% |
| Q4 2019 | $40,000 | +11.1% | 1,196 | +10.0% | 0.00% | +50.0% |
| Q3 2019 | $36,000 | -87.5% | 1,087 | -92.2% | 0.00% | -88.2% |
| Q1 2019 | $288,000 | +569.8% | 13,967 | +511.5% | 0.02% | +750.0% |
| Q2 2018 | $43,000 | +207.1% | 2,284 | +42.4% | 0.00% | 0.0% |
| Q4 2017 | $14,000 | -74.1% | 1,604 | -61.4% | 0.00% | -50.0% |
| Q3 2017 | $54,000 | +575.0% | 4,156 | +551.4% | 0.00% | +300.0% |
| Q2 2016 | $8,000 | -76.5% | 638 | -82.0% | 0.00% | -80.0% |
| Q1 2016 | $34,000 | +100.0% | 3,539 | +124.6% | 0.01% | +150.0% |
| Q3 2015 | $17,000 | – | 1,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |